Results 31 to 40 of about 447,491 (216)

Multiparametric magnetic resonance imaging for radiotherapy response evaluation in high-risk soft tissue sarcoma: A pilot study [PDF]

Phys Imaging Radiat Oncol
van Meekeren M, van Houdt P, Fiocco M, Winfield J, Messiou C, Heeres B, Gelderblom H, Steeghs N, Haas R, van Langevelde K.   +9 more
europepmc   +2 more sources

Surgical margins in the management of extremity soft tissue sarcoma.

Chinese Clinical Oncology, 2018
Standard treatment of localized soft tissue sarcoma should include surgical resection, which can be performed alone or in combination with perioperative radiotherapy and/or chemotherapy.
M. Endo, P. Lin
semanticscholar   +1 more source

Lymphadenectomy in the treatment of sarcomas – indications and technique

Oncology Reviews
Sarcomas are a rare type of malignancy with limited treatment options so far. This analysis aimed to describe the impact of lymphadenectomy on treating sarcoma patients. Sarcomas characterized by lymphatic spread are rare.
Piotr Dunaj, Piotr Dunaj, Ewa Żukowska, Ewa Żukowska, Anna M. Czarnecka, Maria Krotewicz, Aneta Borkowska, Paulina Chmiel, Paulina Chmiel, Tomasz Świtaj, Piotr Rutkowski   +10 more
doaj   +1 more source

The significance of margins in pediatric Non‐Rhabdomyosarcoma soft tissue sarcomas: Consensus on surgical margin definition harmonization from the INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT)

Cancer Medicine, 2023
Background Margin status following surgery in children, adolescents, and young adults with soft tissue sarcomas is controversial and has been defined differently by various specialties, with definitions changing over time and by cooperative group.
Monika Sparber‐Sauer, Andrea Ferrari, Sheri L. Spunt, Christian Vokuhl, Dana Casey, Timothy B. Lautz, William H. Meyer, David O. Walterhouse, Kristian W. Pajtler, Rita Alaggio, Andreas Schmidt, Akmal Safwat, Beate Timmermann, Patrizia Dall'Igna, Sonja Chen, Aaron R. Weiss, Daniel Orbach   +16 more
doaj   +1 more source

Systemic inflammation index is a predictive and prognostic factor in patients with liposarcoma or leiomyosarcoma treated with trabectedin

Scientific Reports
Trabectedin is a chemotherapeutic agent that has shown activity in the treatment of patients with soft tissue sarcomas after failure of anthracycline-based therapy and the best results were recorded in the treatment of L-sarcomas.
Pawel Sobczuk, Paulina Filipowicz, Lukasz Lamparski, Hanna Kosela-Paterczyk, Pawel Teterycz, Katarzyna Kozak, Paweł Rogala, Tomasz Świtaj, Sławomir Falkowski, Piotr Rutkowski   +9 more
doaj   +1 more source

Efficacy of radiotherapy and radiotherapy with hyperthermia to delay change of systemic therapy in patients with metastatic melanoma

Clinical and Translational Radiation Oncology
Background: The use of radiotherapy (RT) and RT with hyperthermia (HT) as a local treatment for oligoprogression in many tumors is becoming increasingly prevalent.
Paulina Chmiel, Mateusz Jacek Spałek, Hanna Koseła-Paterczyk, Piotr Łukasz Rutkowski, Paulina Jagodzińska-Mucha, Paweł Rogala, Katarzyna Kozak, Maria Telejko, Aneta Maria Borkowska   +8 more
doaj   +1 more source

Molecular and Clinicopathological Biomarkers in the Neoadjuvant Treatment of Patients with Advanced Resectable Melanoma

Biomedicines
Neoadjuvant systemic therapy is emerging as the best medical practice in patients with resectable stage III melanoma. As different regimens are expected to become available in this approach, the improved optimization of treatment strategies is required ...
Piotr J. Błoński, Anna M. Czarnecka, Krzysztof Ostaszewski, Anna Szumera-Ciećkiewicz, Piotr Rutkowski   +4 more
doaj   +1 more source

From pathogenesis to the patient’s bedside: a comprehensive review of extraskeletal myxoid chondrosarcoma

Journal of Cancer Research and Clinical Oncology
Extraskeletal myxoid chondrosarcoma (EMC) is characterised by recurrent NR4A3 gene rearrangements, most commonly EWSR1::NR4A3, and accounts for approximately 1–3% of soft-tissue sarcomas (STS). It typically arises in the deep soft tissues of the proximal
Piotr Remiszewski, Sławomir Falkowski, Anna Szumera-Ciećkiewicz, Mateusz J. Spałek, Piotr Rutkowski, Anna M. Czarnecka   +5 more
doaj   +1 more source

Progresses in Fluorescence Imaging Guidance for Bone and Soft Tissue Sarcoma Surgery

Frontiers in Oncology, 2022
R0 surgical resection is the preferred treatment for bone and soft tissue sarcoma. However, there is still a lack of precise technology that can visualize bone and soft tissue sarcoma during surgery to assist the surgeon in judging the tumor surgical ...
Zhenyi Chen, Huayi Huang, Siyuan He, Yi Wang, Lin Cai, Yuanlong Xie   +5 more
doaj   +1 more source

1987TiP Pembrolizumab in combination with eftilagimod alpha and radiotherapy in neoadjuvant treatment of patients with soft tissue sarcomas: EFTISARC-NEO trial [PDF]

, 2023
Katarzyna Kozak, Paweł Sobczuk, Sylwia Kopeć, Tomasz Świtaj, Paweł Teterycz, Aneta Borkowska, Piotr Rutkowski   +6 more
openalex   +1 more source